The first Pfizer trade was made in Q1 2013.
Since then Baillie Gifford bought shares three more times and sold shares on seven occasions. The investor completely sold their stake between Q3 2022 and Q2 2023.
Avg closing price
Price range
Sold -466 shares
Q2 2023
Avg closing price
$38.92
Price range
$36.12
-
$41.79
Sold 6.8% shares (-34 shares)
Q3 2022
Avg closing price
$48.59
Price range
$43.76
-
$53.42
New holding (+500 shares)
Q3 2021
Avg closing price
$44.30
Price range
$39.25
-
$50.42
Sold -341 Thousand shares
Q4 2014
Avg closing price
$30.23
Price range
$27.70
-
$32.09
Sold 87.8% shares (-2.46 Million shares)
Q3 2014
Avg closing price
$29.58
Price range
$28.04
-
$30.96
Sold 39.3% shares (-1.81 Million shares)
Q2 2014
Avg closing price
$30.05
Price range
$29.02
-
$32.40
Sold 1.0% shares (-44.6 Thousand shares)
Q1 2014
Avg closing price
$31.43
Price range
$29.66
-
$32.75
Sold 2.8% shares (-135 Thousand shares)
Q4 2013
Avg closing price
$30.68
Price range
$28.24
-
$32.20
Increased shares by 6.2% (+281 Thousand shares)
Q3 2013
Avg closing price
$28.66
Price range
$27.65
-
$29.67
Increased shares by 7.6% (+317 Thousand shares)
Q2 2013